Cellectar Biosciences, Inc. (CLRB)
$1.45+3.57%Close
SELLCRISIS · day 13
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $5M
- Beta
- 0.58
- P/E (TTM)
- -0.33
- Short % float
- 5.52%
- Days to cover
- 2.0
- SI change
- -13.0%
- 1W
- -18.54%
- 1M
- -38.82%
- vs SPY 1W
- -19.70%
- vs SPY 1M
- -41.81%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on CLRB?
- LOPJLB’s latest quantitative signal on Cellectar Biosciences, Inc. (CLRB) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is CLRB in?
- Cellectar Biosciences, Inc. (CLRB) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Cellectar Biosciences, Inc. (CLRB) do?
- Cellectar Biosciences is a biopharmaceutical firm engaged in the research, development, and market introduction of therapeutic agents to combat cancer. The company's primary asset is CLR 131 (iopofosine I-131), a phospholipid drug conjugate (PDC), which is currently undergoing several clinical evaluations. It is in Phase 2 clinical trials for individuals with relapsed or refractory (r/r) Walden…